The Latest Breaking News on Pharma

The Fed’s aggressive interest rate hikes and high energy prices will likely fuel recessionary conditions. Moreover, the unexpected decline in GDP in the first quarter indicates a possible economic contraction. Amid such possibilities, the pharmaceutical industry could attract investors’ attention because of the inelastic demand for its products. Today, I…

AbbVie Inc (NYSE:ABBV) has ended a research partnership with Sweden's BioArctic, backing out further development of an experimental Parkinson's disease drug and other related medicines. A clinicaltrials.gov listing for ABBV-0805 says a Phase I study is "Withdrawn (Strategic considerations)." The partnership between AbbVie and BioArctic, which began in 2016, was focused on antibody drugs…

Blood products giant CSL says that its ability to collect plasma has been improving as social mobility increases.

Xtandi, a wonder drug for prostate cancer, was developed at UCLA with substantial funding from the taxpayers through the Pentagon and the National Institutes of Health.

KHN's Pharma Cash to Congress database reveals how the drug industry attempts to influence politics

The Biden administration and Congress are embroiled in high-stakes haggling over what urgent priorities will make it into the ever-shrinking social spending bill. But for the pharmaceutical industry there is one agenda: Heading off Medicare drug price negotiation, which it considers an existential threat to its business model.

Portugal is expected to lift quarantine requirements for Britons who have had an Indian-made AstraZeneca vaccine.

WA Premier Mark McGowan joins Queensland Premier Annastacia Palaszczuk in saying people under 40 should not get the AstraZeneca COVID vaccination, based on health advice.

Dr McBride moves to allay any doubts over Astra Zeneca claims and says there are no confirmed cases of South Africa variant of the virus in Northern Ireland